Deep Blue Biotech
Deep Blue BioTech leverages synthetic biology and AI to decarbonize chemicals, replacing fossil-derived alternatives with high-value compounds produced via a novel cyanobacterial platform. Their cost-effective solution initially targets the Pharma, Beauty, and Personal Care industries, with plans to expand to other markets to maximize carbon mitigation. The company highlights the benefits of synthetic biology, including precision, customization, sustainability through renewable feedstocks, and rapid development. Cyanobacteria are emphasized as highly efficient photosynthetic organisms that utilize CO2 as a feedstock, contributing to carbon removal. The company is led by an experienced team with expertise in synthetic biology, sustainable design, and scaling technologies, aiming to move synthetic biology from the lab to the marketplace.
Deep Blue Biotech
Deep Blue BioTech leverages synthetic biology and AI to decarbonize chemicals, replacing fossil-derived alternatives with high-value compounds produced via a novel cyanobacterial platform. Their cost-effective solution initially targets the Pharma, Beauty, and Personal Care industries, with plans to expand to other markets to maximize carbon mitigation. The company highlights the benefits of synthetic biology, including precision, customization, sustainability through renewable feedstocks, and rapid development. Cyanobacteria are emphasized as highly efficient photosynthetic organisms that utilize CO2 as a feedstock, contributing to carbon removal. The company is led by an experienced team with expertise in synthetic biology, sustainable design, and scaling technologies, aiming to move synthetic biology from the lab to the marketplace.